Venture Firm Files to Sell $11k in Werewolf Therapeutics Stock
Werewolf Therapeutics, Inc.
Subscribe to track HOWL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Venture Firm Files to Sell $11k in Werewolf Therapeutics Stock
Company: Werewolf Therapeutics, Inc. (HOWL) Form: 144 | Filed: 2025-11-04 Significance: Low
Insider: MPM BioVentures 2014 (B), L.P. Title: null | Relationship: Shareholder
Transaction: • Type: Proposed Sale • Shares: 8,679 • Price: $1.31 • Value: $11,369 • Owned After: Not Disclosed
Key Insight: A venture capital firm has filed a notice of proposed sale for a very small amount of stock, representing less than 0.02% of the company's market cap. This is a routine filing with minimal market impact.
Market Context: The transaction size is negligible for Werewolf Therapeutics, a nano-cap biotech company with a market capitalization of approximately $60 million.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Werewolf Therapeutics, Inc. (HOWL)
Executive Summary
- Trading Significance: Low
- Key Takeaway: MPM BioVentures 2014 (B), L.P., a shareholder, has filed a notice of intent to sell a nominal amount of Werewolf Therapeutics stock, valued at approximately $11,369.
- Market Impact: The transaction is immaterial and expected to have no discernible impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | Werewolf Therapeutics, Inc. |
| Ticker Symbol | HOWL |
| CIK | 0001785530 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | MPM BioVentures 2014 (B), L.P. |
| CIK | 0001609493 |
| Title/Position | null |
| Relationship | Shareholder |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-04 |
| Transaction Code | S |
| Security Type | Common |
| Shares Involved | 8679 |
| Price Per Share | $1.31 |
| Total Value | $11,369.49 |
| Shares Owned After | Not Disclosed |
| Ownership Type | null |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $11,369.49 |
| % of Market Cap | 0.019% |
| Shares Transacted | 8,679 |
| % of Shares Outstanding | 0.019% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $60 million, this $11k transaction is de minimis.
- Transaction Significance: The sale represents a negligible fraction (0.019%) of both the company's market capitalization and its total shares outstanding, indicating it is not a significant event.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The size of the proposed sale is too small to influence market sentiment or price action.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is not large enough to affect trading volume.
- Sentiment Indicator: Neutral. This is a routine filing by an institutional shareholder with no signaling value.
Additional Context
Transaction Notes
- Form 144: This filing is a notice of a proposed sale of securities, not a completed transaction. The sale is planned to occur around the filing date.
- Special Circumstances: The sale is made under a Rule 10b5-1 trading plan adopted on September 24, 2025, indicating the decision to sell was made in advance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.